| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Internal Medicine, University of Genova, Genova, Italy;
Laboratory of Oncology and
Division of Otolaryngology, Institute G. Gaslini, Genova, Italy; and
§
Institute of Biology and Genetics, University of Ancona, Ancona, Italy
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Leukocyte migration depends on the expression of specific adhesion molecules that allow selective cell homing to different anatomical districts and on the delivery of chemotactic signals that trigger cell locomotion (1, 2). Chemoattractants are heterogeneous in nature and include bacterial components, cytokines, and complement fragments (3). The role of cytokines in the control of human T and B lymphocyte migration is well established (4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16); in contrast, little information is available on the chemotactic activity of complement components vs human lymphocytes.
In this study we have investigated the in vitro migratory response of human tonsillar B lymphocytes to rC5a based upon the following rationale: 1) murine germinal center (GC)3 B cells isolated during an ongoing immune response migrate in vitro upon exposure to C5a (17); and 2) mice with targeted disruption of the C3 and C4 genes display defects in humoral immunity and in the formation of GC (18). The latter findings suggest that C3 or C4 or complement components downstream that are not generated in these knockout animals are involved in the control of B cell trafficking.
Together with C3a and C4a, C5a is one of three low molecular mass peptides referred to as anaphylatoxins (19). The classic and alternate C5 convertases cleave C5a from the 190-kDa C5 disulfide-linked heterodimer; thereafter, C5a is released in fluid phase (20). C5a binds to a specific surface receptor known as CD88 (21, 22). CD88 is a 40-kDa molecule belonging to the G protein-linked transmembrane segment superfamily and expressed on mast cells, basophils, endothelial cells, neutrophils, monocytes-macrophages, lung bronchial and epithelial cells, vascular smooth muscle cells, and hepatocytes (23). The binding of C5a to CD88 is followed by signal transduction and initiates a wide range of proinflammatory effects (23). For example, C5a promotes chemotaxis and chemokinesis of neutrophils (24) and increases their adhesiveness by up-regulating CD11b (25). Recently, it has been shown that human dendritic cells (26) and mast cells (27) also migrate in response to rC5a. To date, there has been no demonstration of the expression of CD88 on human B lymphocytes or of a chemotactic activity of C5a toward these cells.
Here we show that human tonsillar B cells, in particular the memory and naive cell populations, express CD88, polarize, and migrate in vitro upon incubation with rC5a. The essential role of CD88 in rC5a-triggered B cell locomotion was demonstrated by the abrogation of the phenomenon upon pretreatment of B cell suspensions with a CD88 mAb.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Mononuclear cells were isolated from surgically removed tonsils on Ficoll-Hypaque density gradients and were depleted of T cells by rosetting with neuraminidase-treated SRBC. Non-T cells were subsequently deprived of macrophages and NK cells by incubation with the CD68 and CD56 mAbs (see below) followed by rosetting with ox-E coated with a goat anti-mouse Ig antiserum (28). The resulting cell preparations contained consistently >98% B cells, as assessed by staining with a CD19 mAb.
Fractionation of total tonsillar B lymphocytes into GC, naive, and memory cells was performed as follows. Naive B lymphocytes were isolated as IgD+ cells from total B lymphocyte suspensions by immune rosetting (29). The IgD- B cell fractions were further separated into CD38+ (GC) cells and CD38- (memory) cells by immune rosetting (29). All the above separation procedures were performed at 4°C to prevent spontaneous apoptosis of GC B cells.
In some experiments, tonsillar B lymphocytes or their purified cell subsets were cultured for the indicated times with or without a CD40 mAb (1 µg/ml; see below) and 10 ng/ml rIL-4 (Genzyme, Milan, Italy).
Immunophenotypic analysis
The murine mAbs used in this study were CD3, CD10, CD19, CD23, CD56, CD68, and anti-human IgD (Dako, Glostrup, Denmark); CD39 and CD40 from Immunotech (Marseilles, France); and CD88 from Serotec (Oxford, U.K.). The CD38 mAb used throughout this study (clone IB4) was produced by one of us (F.M.) (30). Goat anti-human IgM and IgG mAbs and the FITC-conjugated goat anti-mouse Ig antiserum were obtained from Dako. In brief, B cells (5 x 105) were treated at 4°C for 30 min with optimal concentrations of mAbs, washed twice in PBS supplemented with 2% FCS, and further incubated with FITC-conjugated goat anti-mouse Ig. Stained cells were analyzed by flow cytometry with a FACScan (Becton Dickinson, Mountain View, CA). Controls were untreated cells, cells treated with FITC-second reagent alone, and cells treated with irrelevant isotype-matched mAb followed by the FITC-second reagent.
Polarization assay
The B cell fractions were resuspended in RPMI 1640 medium supplemented with 0.1% BSA (Sigma, St. Louis, MO) and mixed with human rC5a (Sigma) at concentrations ranging from 0.1–10,000 nM. Experiments were conducted using polystyrene round-bottom tubes (LP, Milan, Italy). The tubes, containing 200 µl of cell suspension at a concentration of 2 x 106/ml, were incubated for 20 min at 37°C; thereafter, 200 µl of 10% formaldehyde was added. The fixed cell suspensions were examined at x400 magnification. At least 200 cells were counted in each preparation. Cells deviating from a spherical outline were scored as polarized and expressed as a percentage of the total number of cells counted (31).
Migration assay
Cell locomotion was studied using the leading front method (32). Tests were conducted in duplicate using blind well chambers (Nucleopore, Cambridge, MA) with an 8-µm pore size cellulose ester filter (SCWPO 1300, lot R4 MM58776, Millipore, Milan, Italy) separating the cells (4 x 105) from the chemoattractant tested at different concentrations or from medium alone (control). After incubation at 37°C for 2 h, the filters were removed, fixed in ethanol, stained with Harris hematoxylin, dehydrated, cleared with xylene, and mounted in Eukitt (Kindler, Freiburg, Germany). Duplicate chambers were run in each case, and the distance (microns) travelled by the leading front of cells was measured at x400 magnification. Five randomly chosen fields were read for each filter. In some experiments, B cell fractions were preincubated with the CD88 mAb (10 µg/ml) or an isotype-matched mAb of irrelevant specificity for 30 min at 4°C and washed. Thereafter, the migration assays were conducted as described above.
The filters were also scored by counting the number of cells per high power field at intervals of 10 µm into the depth of the filter. Five measurements were performed at each focal plane, and the mean of the determinations from the duplicate filters was calculated. The results obtained were analyzed, plotting the log10 of the number of cells per high power field vs the square of the distance travelled by the cells, according to the method of Zigmond and Hirsch (33).
Collagen invasion assay
Type I collagen solution was purchased from Sigma (catalogue no. C4580, lot 126H4667). Gels were prepared according to the Sigma protocol. Briefly, 800 µl of collagen solution was mixed with 100 µl of 10x Earle’s buffered saline and 100 µl of reconstitution buffer (2.2% sodium bicarbonate in 0.8 N sodium hydroxide) to restore collagen to physiological pH and osmolarity. Thereafter, collagen solution (final gel concentration, 0.88 mg/ml) was allowed to gel in 24-well plates in the absence or the presence of the chemoattractants, 10 nM rC5a or 1 ng/ml rTNF (BioSource International, Camarillo, CA), in duplicate. After gelification, cells (8 x 105/well) were overlaid on the gel surface and incubated at 37°C for 10 h. At the end of incubation, gels were fixed for 30 min with 2.5% glutaraldehyde, and cell migration was measured as the distance between the top of the gel and the plane in which the two faster cells invading the gel were in focus (x100 original magnification) (10).
Checkerboard analysis
Assays of cell migration with different doses of rC5a (0, 1, and 10 nM) on both sides of the filter were also performed (33). The results of these experiments were collected in checkerboard form by which chemokinesis (i.e., change in the intensity of random locomotion) and chemotaxis (i.e., change in the directional response to the stimulus) were calculated according to the method of Zigmond and Hirsch (33).
Western blot
Purified B lymphocytes (2.5 x 106) were washed twice with ice-cold PBS and lysed in 100 µl of a solution containing 1% Triton X-100, 50 nM Tris-HCl (pH 7.5), 1 mM DTT, 0.5 M EDTA (pH 8), 1 mM PMSF, and 5 mM benzamidine on ice for 15 min. After centrifugation (10,000 x g, 10 min, 4°C) supernatants were recovered. Cell lysates were separated in 8% SDS-PAGE and transferred onto nitrocellulose filters (Hybond-C Extra, Amersham, Aylesbury, U.K.). The filters were pretreated with 2.5% skim milk, 0.5% BSA, and 0.05% Tween-20 in Tris-buffered saline (TBS) and reacted with goat anti-human C5 antiserum (Quidel, San Diego, CA) or with goat nonimmune serum as a control at room temperature for 1 h. After washing, the filter was incubated with horseradish peroxidase-conjugated rabbit anti-goat Igs (Dako) at room temperature for 1 h. The protein bands were subsequently visualized by using SuperSignal ULTRA chemiluminescent substrate (Pierce, Rockford, IL) in accordance with the manufacturer’s manual.
Immunohistochemistry
Cryostatic tonsillar tissue sections were air-dried at room temperature for 6 h and were fixed with cold acetone for 5 min. Endogenous peroxidases were blocked with 0.3% H2O2 in TBS. The CD88 mAb was diluted 1/100 in TBS and layered onto tissue sections overnight at 4°C. After three washings, a rabbit anti-mouse Ig antiserum (Dako) was incubated with the sections for 30 min, and the reaction was revealed using a two-step alkaline-phosphatase anti-alkaline phosphatase (APAAP) method (34). The chromogen used was Fast Blue BB salt (Sigma), which reacts with Naphtol AS-TR phosphate, and it was applied on tissue sections for 20 min (34). A CD20 mAb (Dako) diluted 1/100 was subsequently layered on the same sections for 3 h at room temperature. Thereafter, a biotinylated rabbit anti-mouse Ig antiserum (Dako) was added for 30 min, followed by a 30-min incubation with StreptABComplex (Dako). The second chromogen used was 3-amino-9-ethylcarbazole (Sigma), which was applied for 15 min according to the instructions of the manufacturer. Sections were finally counterstained with methyl green and mounted in gelatin (34). Repeated washings with TBS were performed at each of the above-described steps. Control experiments were performed by incubation of sections with a secondary Ab alone or with irrelevant primary mAbs of the same isotype as that of the relevant primary mAb.
RNA analysis by RT-PCR
Total RNA was extracted from B cells according to the method of Chomczynski and Sacchi (35) and were reverse transcribed into cDNA by means of a commercial kit (Clontech, Palo Alto, CA) using oligo(dT) as primer. Each cDNA was then diluted to a final volume of 100 µl, and the efficiency of RT was evaluated by amplification of 5 µl of cDNA with the GAPDH primers supplied with the kit. Afterward for each PCR analysis 5 µl of cDNA was amplified in a 50-µl reaction by adding 25 pmol of each specific primer and 2 U of Taq polymerase (Clontech). The primers used were the following: C5 forward primer, CTC CAG GTT CAT CTG TCT CC; and C5 reverse primer, GAA TTT CTG GCT TGC TTA CTG G.
The amplification profile was 1 min at 94°C, 1 min at 60°C, and 1 min at 72°C. The amplification was conducted for 35 cycles, and the amplified product was visualized on a 2% agarose gel stained with ethidium bromide. Preliminary control experiments showed that these primers did not generate any band when tested with genomic DNA. The specificity of the amplification product was checked by Southern blot hybridization of the amplified band with the following internal oligonucleotide: GCC AAT GTG TTC CAC CTA GCT GGA CTT ACC.
Statistical analysis
The results are expressed as the mean ± 1 SD. Differences among groups were determined by the nonparametric Mann-Whitney U test. Differences among groups in dose-response experiments were determined using Kruskal-Wallis nonparametric ANOVA followed by Dunn’s test for multiple comparison. Significance was accepted when p < 0.05 (36, 37).
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
B lymphocytes were purified (>98%) from human tonsillar
mononuclear cells by sequential depletion of T cells, NK cells, and
macrophages and were tested for their ability to undergo polarization
and locomotion in the presence or the absence of various rC5a
concentrations. As shown in Fig. 1
A, tonsillar B lymphocytes
displayed a spontaneous polarization that was increased in a
dose-dependent manner by rC5a, with a statistically significant
difference at concentrations of 1 and 10 nM (p
< 0.05 and p < 0.01, respectively). With increasing
rC5a concentrations, a return of polarization to the background values
was observed, although with some fluctuations (Fig. 1A).
Similar results were obtained when B cells were tested for their
ability to migrate through a nitrocellulose filter. The spontaneous
locomotion of B lymphocytes was augmented significantly by 1 and 10 nM
rC5a (p < 0.05 and p < 0.01,
respectively), with a decrease to the baseline values at higher rC5a
concentrations (Fig. 1B). Thus, the dose-response
experiments show the typical bell-shaped curve obtained with most
chemoattractants. Based upon these results, all subsequent experiments
were conducted using 10 nM rC5a. Next, the B cell chemoattractant
activity of rC5a was tested in the collagen invasion assay, which
mimics the events occurring in vivo during cell migration. In these
experiments rC5a was compared with rTNF, which was recently described
as a potent B cell chemoattractant (11). As shown in Fig. 2, both rTNF and rC5a significantly
enhanced the spontaneous penetration of tonsillar B cells into the
collagen matrix (p < 0.05).
|
|
, rC5a stimulated both the rate of cell
locomotion and the true chemotaxis. In particular, taking into account
spontaneous migration (i.e., in the absence of rC5a above and below the
filter), 10 nM rC5a above and below the filter (chemokinetic
conditions) enhanced cell migration by 34.8 ± 20.9% (mean
± 1 SD; n = 3). On the other hand, compared with B
cell migration in the absence of rC5a above and below the filter (i.e.,
spontaneous migration), 10 nM rC5a placed only below the filter
(chemotactic conditions) augmented cell migration by 46.2 ± 5.0%
(mean ± 1 SD; n = 3). On the contrary, cell
migration in negative gradients was consistently lower than that
calculated on the basis of the expected response to absolute
concentration alone.
|
An analysis of the distribution of purified tonsillar B
lymphocytes through the filter in response to 10 nM rC5a is shown in
Fig. 3. This representation allows
assessment of whether the distance travelled by the leading front is
representative of the movement of the whole migrating population or,
rather, of only a faster cell subgroup (33). The logarithm of the
number of cells at a given distance was plotted vs the square of the
distance (33). The data expressed in this way were found to fit better
with the logarithmic relationship (r = 0.98882,
F = 219.85969, p < 0.0001), than with
the linear relationship (r = 0.93639, F
= 35.59577, p < 0.0019), characteristic of a uniformly
migrating population (Fig. 3) (33). These findings suggested that the B
cell fractions tested contained at least two cell subsets with
different migratory capabilities.
|
Tonsillar B lymphocytes are comprised of three major cell
populations, i.e., GC, naive, and memory B lymphocytes (29, 38, 39, 40, 41, 42).
These cell fractions differ as for immunophenotype, anatomical
location, and functional features (38, 39, 40, 41, 42, 43). To investigate what B cell
subset(s) were the targets of the rC5a-mediated chemotactic
enhancement, purified tonsillar B lymphocytes were separated into naive
(IgD+, CD38-), GC (CD38+,
IgD-) and memory (CD38-, IgD-)
cells (29, 38, 39, 40, 41, 42, 44) before being tested for locomotion in the
presence or the absence of rC5a. Consistent with previous reports (29, 43, 44) most IgD+ naive B cells were CD39+,
IgM+, IgG-, CD38-,
CD10-, whereas approximately one-half of them expressed
the CD23 marker (not shown). CD38+, IgD- GC B
cells were CD10+, CD39-, CD23-
(not shown). IgD-, CD38- memory B lymphocytes
were predominantly CD39+, IgG+,
CD23-, CD10- (not shown) (29, 43, 44). As
shown in Fig. 4, memory B lymphocytes
displayed a high degree of spontaneous migration that was increased
significantly by the exposure to rC5a (p <
0.05; Fig. 4). Naive B cells exhibited a lower spontaneous locomotion
that was augmented significantly by rC5a (p <
0.05; Fig. 4). The migratory response of memory B lymphocytes to rC5a
was significantly higher than that of naive B cells
(p < 0.005; Fig. 4). Finally, the spontaneous
migration of GC B cells was unaffected by treatment with rC5a (Fig. 4).
Control experiments ruled out that the failure of GC B lymphocytes to
migrate in vitro in response to rC5a was related to their propensity to
undergo apoptosis (41). Thus, all the separation procedures were
conducted at 4°C to prevent spontaneous apoptosis, and freshly
isolated GC B cells contained consistently >90% viable lymphocytes,
as assessed by trypan blue staining. An equivalent proportion of viable
GC B lymphocytes was detected after 2-h incubation for the locomotory
assays.
|
CD88 is expressed by tonsillar B lymphocytes and is involved in their migratory response to rC5a
The binding of C5a to the cell surface is mediated by a
single class of receptors (CD88) that are widely distributed among
different cell types (23). In subsequent experiments, the expression of
CD88 on freshly isolated memory, naive, and GC B cells was
investigated. Flow cytometric analysis of the three B cell fractions
showed that memory and naive B lymphocytes expressed CD88 (ranges from
four different experiments: 33–47% and 10–14%, respectively),
whereas GC B cells did not (Fig. 5).
Notably, no CD88 expression was detected on GC B cells that had been
cultured for 6–24 h with CD40 mAb and IL-4. In subsequent experiments
the in vivo localization of CD88+ cells was investigated by
double staining of frozen tonsillar tissue sections with CD88 and CD20
mAbs. The majority of CD88+ cells were CD20-
macrophages that stained blue (Fig. 6,
A and B, APAAP staining) and localized
predominantly to the interfollicular and subepithelial areas (Fig. 6A); few CD88+, CD20- macrophages
were found in the follicular mantle (Fig. 6B).
CD20+, CD88- B lymphocytes were enriched in
the follicles and stained brown (Fig. 6, A and B,
peroxidase staining). CD88+ cells that coexpressed CD20
were detected in the subepithelial areas below the crypts (Fig. 6C). These CD88+, CD20+ lymphocytes
stained violet due to the overlapping of blue and brown stainings at
the surface of the same cell (Fig. 6C). Taken together, the
immunohistochemical analyses showed that a proportion of tonsillar
CD88+ cells were of B cell lineage and localized in an
anatomical district, i.e., the subepithelial area, where the majority
of memory B cells home (44).
|
|
), were incubated
with medium alone, CD88 mAb, or an isotype-matched control mAb and were
tested in the nitrocellulose filter assay. Exposure of memory B cells
to the CD88 mAb abrogated their migratory response to rC5a
(CD88-treated B cell spontaneous migration vs C5a-induced migration: no
significant difference), whereas treatment with the control mAb left
the latter response unaltered (control mAb-treated B cell spontaneous
migration vs C5a-induced migration, p < 0.05; Fig. 7).
|
In the following experiments the hypothesis that the C5
gene could be expressed in tonsillar B cell subsets was investigated.
To this end, RNA was extracted from freshly isolated naive, GC, and
memory B lymphocytes; reverse transcribed; and subjected to RT-PCR. As
shown in Fig. 8A, C5
transcripts were detected in the three B cell subsets; the specificity
of the amplification products was confirmed by Southern blot
hybridization of the same filters with an internal oligonucleotide (not
shown). Next, Western blot experiments with freshly isolated memory,
naive, and GC B cells were conducted using an anti-C5 goat
antiserum to demonstrate the presence of the C5 protein. As shown in
Fig. 8B, two bands of the expected molecular masses, i.e.,
115 and 75 kDa, respectively, were detected in the cell lysates from
the three B cell fractions under reducing conditions. Such bands
correspond to the 
- and ß-chains of the C5 molecule, respectively
(20). These experiments suggest that C5 produced in vivo by freshly
isolated memory, naive, and GC tonsillar B lymphocytes may serve
as substrate for the generation of biologically active C5a in secondary
lymphoid tissues.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Here we have investigated the in vitro locomotory response of human tonsillar B lymphocytes to rC5a. rC5a significantly enhanced their spontaneous polarization and migration through an increased rate of locomotion, i.e., chemokinesis, and an increased directional migration, i.e., chemotaxis. When tonsillar B cells were fractionated into the naive, GC, and memory cell subsets it was found that memory and, to a lesser extent, naive B lymphocytes migrated in vitro in response to rC5a, whereas GC B cells did not. Accordingly, memory and naive B lymphocytes expressed CD88, as assessed by flow cytometry, and preincubation of memory B cells with a CD88 mAb abrogated their migratory responsiveness to rC5a.
The observed hierarchical responses of memory, naive, and GC B lymphocytes to rC5a may relate to their migratory properties in vivo. Naive B cells migrate from the bone marrow to the secondary lymphoid organs, where, in the absence of interaction with Ag, either die or are recruited into a pool of cells that recirculate through blood and secondary lymphoid organs (52, 53). Here, following encounter with Ag in the T zone, naive B cells undergo clonal expansion and colonize the primary lymphoid follicles, where they differentiate into GC cells. A wave of cell proliferation is followed by somatic hypermutation of Ig variable region genes and positive selection of GC B cells according to the affinity of surface Ig for Ag displayed on follicular dendritic cells (FDC) (38, 39, 40, 41, 52, 53). Positively selected GC B cells differentiate into memory or plasma cells, whereas most nonselected cells undergo apoptosis without leaving the lymphoid follicle (38, 39, 40, 41, 52, 53).
GC B lymphocytes freshly isolated from human tonsils have little propensity to locomotion (Refs. 11, 25, and 45 and this study), perhaps due to the lack of expression of CD44 (29, 54) or L-selectin (29), which allows cell binding to specialized postcapillary high endothelial venules (55). Upon short term culture with CD40 mAb and IL-4, GC B cells acquire migratory competence, and their baseline locomotion can be further enhanced by the exposure to some stimuli, such as anti-Ig and CD32 Abs (45), but not to others, as demonstrated for C5a in this study. Kupp and co-workers have previously shown that GC B cells isolated from murine lymph nodes 2–4 days after antigenic stimulation migrated in vitro upon exposure to C5a generated from zymosan-treated serum (17). The human counterpart of these cells may be a small GC B cell fraction (56) that displays an IgD+, IgM+, CD38+ immunophenotype and, in part, germline Ig genes (56). These cells have been defined as GC founder, since they may represent the "trait-d’union" between naive and GC B lymphocytes (56). Alternatively, murine GC B cells that were isolated during an ongoing immune response could have received in vivo signals that primed them for a migratory response to C5a.
In immunized mice splenic memory B cells have been localized predominantly to the marginal zone (57); shortly after antigenic challenge, specific B lymphocytes disappear from the marginal zone due to their migration into the follicles and subsequently to the T cell zones. Thereafter, memory B cells either move to the splenic red pulp where they differentiate to plasma cells or return to the marginal zone 3 days after immunization. Thus, the locomotion of memory B lymphocytes depends on their Ag-activated state (57, 58). In human tonsils, IgD-, CD38- memory B cells are found within and underneath the epithelium lining the crypts (44). In this study the findings that CD88+ B lymphocytes were detected in the subepithelial areas where the bulk of memory B cells settle (44) and that freshly purified memory B lymphocytes were the most motile cells in response to rC5a support the hypothesis that C5a is an important chemoattractant for memory B lymphocytes in vivo.
C5 gene expression was here demonstrated in freshly isolated naive, GC, and memory B lymphocytes at both the mRNA and the protein level. This finding is in line with a previous report showing that human T and B lymphoblastoid cell lines can synthesize C5 (59) and raises the possibility that not only macrophages, but also the B cells themselves, serve as sources of C5 in the secondary lymphoid tissues. Since FDC retain Ag-antibody complexes on their surface (41), it is tempting to speculate that C5a is generated in the lymphoid follicles via classic complement activation triggered by FDC-bound immune complexes. It is also conceivable that follicular macrophages handling immune complexes contribute to C5a production. Locally produced C5a, in turn, might be involved in the control of short range migration of memory and naive B lymphocytes.
The B cell-directed chemotactic activity of C5a may help understand the
mechanisms of B lymphocyte recruitment to inflamed tissues, such as,
for example, the synovial membrane in rheumatoid arthritis (60) and the
salivary glands in Sjogren’s syndrome (61). C5a generated in these
sites by classic and/or alternate C5 convertases would increase
endothelial permeability and promote the extravasation of B lymphocytes
to the tissues, where GC formation is frequently observed (60, 61). In
this connection, C3 gene expression can be up-regulated by T
cell-derived IFN-
released in the microenvironment of secondary
lymphoid follicles (62). The increased availability of C3 in the course
of acute or chronic inflammation might lead to augmented generation of
C5a with consequent enhancement of B cell locomotion.
In conclusion, this study delineates a novel role for C5a in B lymphocyte-dependent immune responses and provides clues that may provide a better understanding of the pathophysiology of autoimmune and lymphoproliferative disorders.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Luciano Ottonello, Semeiotica Medica 2, Dipartimento di Medicina Interna, Viale Benedetto XV 6, I-16132 Genova, Italy. E-mail address:
3 Abbreviations used in this paper: GC, germinal center; APAAP, alkaline-phosphatase anti-alkaline phosphatase; FDC, follicular dendritic cells.
Received for publication December 4, 1998. Accepted for publication March 10, 1999.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
(MIP-1) and MIP-1ß chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1821. activate locomotor capacity in human B lymphocytes. Immunology 67:237.[Medline]
up-regulates expression of the complement components C3 and C4 by stabilization of mRNA. J. Immunol. 156:4429.[Abstract]
This article has been cited by other articles:
|
|
 |
|
  S. Nemali, D. W. Siemsen, L. K. Nelson, P. L. Bunger, C. L. Faulkner, P. Rainard, K. A. Gauss, M. A. Jutila, and M. T. Quinn Molecular analysis of the bovine anaphylatoxin C5a receptor J. Leukoc. Biol., August 1, 2008; 84(2): 537 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Connelly, R. A. Moulton, A. K. Smith, D. R. Lindsey, M. Sinha, R. A. Wetsel, and C. Jagannath Mycobacteria-primed macrophages and dendritic cells induce an up-regulation of complement C5a anaphylatoxin receptor (CD88) in CD3+ murine T cells J. Leukoc. Biol., January 1, 2007; 81(1): 212 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Wenderfer, B. Ke, T. J. Hollmann, R. A. Wetsel, H. Y. Lan, and M. C. Braun C5a Receptor Deficiency Attenuates T Cell Function and Renal Disease in MRLlpr Mice J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3572 - 3582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Addis-Lieser, J. Kohl, and M. G. Chiaramonte Opposing Regulatory Roles of Complement Factor 5 in the Development of Bleomycin-Induced Pulmonary Fibrosis J. Immunol., August 1, 2005; 175(3): 1894 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Baelder, B. Fuchs, W. Bautsch, J. Zwirner, J. Kohl, H. G Hoymann, T. Glaab, V. Erpenbeck, N. Krug, and A. Braun Pharmacological Targeting of Anaphylatoxin Receptors during the Effector Phase of Allergic Asthma Suppresses Airway Hyperresponsiveness and Airway Inflammation J. Immunol., January 15, 2005; 174(2): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. J. Kim, I. D. Dimitriou, M. C. H. Holland, D. Mastellos, Y. M. Mueller, J. D. Altman, J. D. Lambris, and P. D. Katsikis Complement C5a Receptor Is Essential for the Optimal Generation of Antiviral CD8+ T Cell Responses J. Immunol., August 15, 2004; 173(4): 2524 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Boshra, J. Li, R. Peters, J. Hansen, A. Matlapudi, and J. O. Sunyer Cloning, Expression, Cellular Distribution, and Role in Chemotaxis of a C5a Receptor in Rainbow Trout: The First Identification of a C5a Receptor in a Nonmammalian Species J. Immunol., April 1, 2004; 172(7): 4381 - 4390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ghio, L. Ottonello, P. Contini, M. Amelotti, C. Mazzei, F. Indiveri, F. Puppo, and F. Dallegri Transforming growth factor-{beta}1 in supernatants from stored red blood cells inhibits neutrophil locomotion Blood, August 1, 2003; 102(3): 1100 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Beyer, M. Meyer-Hermann, and G. Soff A possible role of chemotaxis in germinal center formation Int. Immunol., December 1, 2002; 14(12): 1369 - 1381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Corcione, G. Tortolina, R. Bonecchi, N. Battilana, G. Taborelli, F. Malavasi, S. Sozzani, L. Ottonello, F. Dallegri, and V. Pistoia Chemotaxis of human tonsil B lymphocytes to CC chemokine receptor (CCR) 1, CCR2 and CCR4 ligands is restricted to non-germinal center cells Int. Immunol., August 1, 2002; 14(8): 883 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Bjorgan, J. E. Thoen, J. B. Natvig, and K. M. Thompson Bm1-Bm5 Classification of Peripheral Blood B Cells Reveals Circulating Germinal Center Founder Cells in Healthy Individuals and Disturbance in the B Cell Subpopulations in Patients with Primary Sjogren's Syndrome J. Immunol., October 1, 2001; 167(7): 3610 - 3618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lindhout, J. L. M. Vissers, F. C. Hartgers, R. J. F. Huijbens, N. M. Scharenborg, C. G. Figdor, and G. J. Adema The Dendritic Cell-Specific CC-Chemokine DC-CK1 Is Expressed by Germinal Center Dendritic Cells and Attracts CD38-Negative Mantle Zone B Lymphocytes J. Immunol., March 1, 2001; 166(5): 3284 - 3289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kacani, Z. Banki, J. Zwirner, H. Schennach, Z. Bajtay, A. Erdei, H. Stoiber, and M. P. Dierich C5a and C5adesArg Enhance the Susceptibility of Monocyte-Derived Macrophages to HIV Infection J. Immunol., March 1, 2001; 166(5): 3410 - 3415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yang, Q. Chen, S. Stoll, X. Chen, O. M. Z. Howard, and J. J. Oppenheim Differential Regulation of Responsiveness to fMLP and C5a Upon Dendritic Cell Maturation: Correlation with Receptor Expression J. Immunol., September 1, 2000; 165(5): 2694 - 2702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Corcione, L. Ottonello, G. Tortolina, P. Facchetti, I. Airoldi, R. Guglielmino, P. Dadati, M. Truini, S. Sozzani, F. Dallegri, et al. Stromal Cell-Derived Factor-1 as a Chemoattractant for Follicular Center Lymphoma B Cells J Natl Cancer Inst, April 19, 2000; 92(8): 628 - 635. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
) or the absence (
)
of 10 nM rC5a. Data are the mean ± 1 SD of four experiments. In
the presence of rC5a, memory and naive, but not GC, B cells migrated
faster than the corresponding unstimulated cell fractions
(p < 0.05, by nonparametric Mann-Whitney
U test). Furthermore, in the presence of rC5a, memory
and naive B lymphocytes displayed a significantly higher degree of
locomotion than GC B cells (p < 0.005), and memory
B cells migrated faster than naive B cells (p <
0.005).
